Skip to main navigation Skip to search Skip to main content

Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction

  • Thomas Pilgrim
  • , Pascal Vranckx
  • , Marco Valgimigli
  • , Giulio G. Stefanini
  • , Raffaele Piccolo
  • , Julie Rat
  • , Martina Rothenbühler
  • , Stefan Stortecky
  • , Lorenz Räber
  • , Stefan Blöchlinger
  • , Lukas Hunziker
  • , Sigmund Silber
  • , Peter Jüni
  • , Patrick W. Serruys
  • , Stephan Windecker
  • University Hospital of Psychiatry
  • Department of Cardiac Intensive Care and Interventional Cardiology
  • Humanitas Research Hospital
  • Heart Center at Isar
  • Li Ka Shing Knowledge Institute
  • Imperial College London

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

74 Citations (Scopus)

Abstract

Background We aimed to compare differences in risk and timing of recurrent ischemic events among patients with stable ischemic heart disease (SIHD), non-ST-segment elevation acute coronary syndrome (NSTE-ACS), and ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). Methods We performed an individual data pooled analysis of 5 randomized controlled all-comer trials including a total of 8,859 patients and investigated the risk and timing of recurrent ischemic events among patients with SIHD (n = 3,543), NSTE-ACS (n = 3,364), and STEMI (n = 1,952) throughout 2 years of follow-up. Results At 2 years, all-cause mortality was higher among patients with STEMI (6.4%) and NSTE-ACS (6.1%) compared with those with SIHD (4.2%) (STEMI vs SIHD: Hazard ratio [HR] 1.40, 95% CI 1.09-1.78, P =.007; NSTE-ACS vs SIHD: 1.40, 95% CI 1.13-1.73, P =.002). In a landmark analysis, the risk of mortality among patients with STEMI compared with those with SIHD was confined to the first 30 days after PCI (HR 6.19, 95% CI 3.15-12.16, P <.001) but was similar between 30 days and 2 years (HR 1.00, 95% CI 0.76-1.33, P =.974) (Pinteraction <.001). Conversely, patients with NSTE-ACS had a higher risk of mortality compared with those with SIHD both within the first 30 days (HR 2.19, 95% CI 1.08-4.47, P =.031) and beyond (HR 1.34, 95% CI 1.07-1.67, P =.012) (Pinteraction <.001). A similar pattern in the differential timing of events was observed for cardiac death. Beyond 30 days, the risk of myocardial infarction was comparable in patients with STEMI and SIHD, whereas the risk in patients with NSTE-ACS was increased (HR 1.65, 95% CI 1.23-2.21, P =.001). Conclusion Whereas patients with NSTE-ACS are at increased risk for death at any time after PCI, the mortality of STEMI patients is higher during the first 30 days after PCI but not thereafter compared with patients with SIHD.

Original languageEnglish
Pages (from-to)56-65
Number of pages10
JournalAmerican Heart Journal
Volume175
DOIs
Publication statusPublished - 1 May 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction'. Together they form a unique fingerprint.

Cite this